tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

NUVB Stock Latest News

3 ‘Strong Buy’ Russell 2000 Stocks with Triple-Digit Upside Potential
Market News3 ‘Strong Buy’ Russell 2000 Stocks with Triple-Digit Upside Potential
14h ago
AURA
NUVB
Nuvation Bio management to meet virtually with B. Riley
PremiumThe Fly
Nuvation Bio management to meet virtually with B. Riley
6d ago
NUVB
Nuvation Bio management to meet with B. Riley
PremiumThe Fly
Nuvation Bio management to meet with B. Riley
6d ago
NUVB
Nuvation Bio’s Strategic Positioning and Financial Strength Justify Buy Rating
PremiumRatings
Nuvation Bio’s Strategic Positioning and Financial Strength Justify Buy Rating
19d ago
NUVB
Nuvation Bio announces taletrectinib as preferred agent in NCCN Guidelines
PremiumThe Fly
Nuvation Bio announces taletrectinib as preferred agent in NCCN Guidelines
19d ago
NUVB
Nuvation Bio price target lowered to $6 from $10 at RBC Capital
PremiumThe FlyNuvation Bio price target lowered to $6 from $10 at RBC Capital
26d ago
NUVB
Buy Rating for Nuvation Bio’s IBTROZI: FDA Approval and Competitive Edge in ROS1+ NSCLC Treatment
Premium
Ratings
Buy Rating for Nuvation Bio’s IBTROZI: FDA Approval and Competitive Edge in ROS1+ NSCLC Treatment
30d ago
NUVB
Nuvation Bio’s IBTROZI Receives FDA Approval
Premium
Company Announcements
Nuvation Bio’s IBTROZI Receives FDA Approval
1M ago
8K
NUVB
Nuvation Bio down 9% after FDA approves Ibtrozi
PremiumThe Fly
Nuvation Bio down 9% after FDA approves Ibtrozi
1M ago
NUVB
Warnings for Nuvation’s Ibtrozi as expected, says JonesResearch
PremiumThe Fly
Warnings for Nuvation’s Ibtrozi as expected, says JonesResearch
1M ago
NUVB
Nuvation Bio trading resumes
PremiumThe Fly
Nuvation Bio trading resumes
1M ago
NUVB
Nuvation Bio announces FDA approval of Ibtrozi for advanced ROS-1+ NSCLC
PremiumThe Fly
Nuvation Bio announces FDA approval of Ibtrozi for advanced ROS-1+ NSCLC
1M ago
NUVB
Nuvation Bio trading halted, news pending
PremiumThe FlyNuvation Bio trading halted, news pending
1M ago
NUVB
FDA announces apporval of Nuvation Bio’s Ibtrozi for lung cancer
Premium
The Fly
FDA announces apporval of Nuvation Bio’s Ibtrozi for lung cancer
1M ago
NUVB
Nuvation kinase inhibitor wins FDA approval in non-small cell lung cancer
Premium
The Fly
Nuvation kinase inhibitor wins FDA approval in non-small cell lung cancer
1M ago
NUVB
Nuvation Bio jumps 4% to $2.64 after FDA approves Ibtrozi
PremiumThe Fly
Nuvation Bio jumps 4% to $2.64 after FDA approves Ibtrozi
1M ago
NUVB
Nuvation Bio’s Strategic Positioning and Potential FDA Approval: Analyst Recommends Buy Rating
PremiumRatings
Nuvation Bio’s Strategic Positioning and Potential FDA Approval: Analyst Recommends Buy Rating
2M ago
NUVB
Nuvation Bio Holds Successful Annual Meeting 2025
PremiumCompany Announcements
Nuvation Bio Holds Successful Annual Meeting 2025
2M ago
8K
NUVB
Nuvation Bio’s Positive Outlook: Taletrectinib Approval and Financial Strength
PremiumCompany Announcements
Nuvation Bio’s Positive Outlook: Taletrectinib Approval and Financial Strength
2M ago
NUVB
Buy Recommendation for Nuvation Bio: Promising Clinical Results and Strong Financial Position
PremiumRatingsBuy Recommendation for Nuvation Bio: Promising Clinical Results and Strong Financial Position
2M ago
NUVB
Nuvation Bio: Undervalued Growth Potential with Key Developments on the Horizon
Premium
Ratings
Nuvation Bio: Undervalued Growth Potential with Key Developments on the Horizon
2M ago
NUVB
Nuvation Bio Reports Q1 2025 Results and Business Updates
Premium
Company Announcements
Nuvation Bio Reports Q1 2025 Results and Business Updates
2M ago
NUVB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >